olmesartan has been researched along with cv 11194 in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (cv 11194) | Trials (cv 11194) | Recent Studies (post-2010) (cv 11194) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 6 | 0 | 0 |
| Protein | Taxonomy | olmesartan (IC50) | cv 11194 (IC50) |
|---|---|---|---|
| Type-1 angiotensin II receptor | Bos taurus (cattle) | 0.55 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
1 review(s) available for olmesartan and cv 11194
| Article | Year |
|---|---|
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |